Logo image of AMED

AMEDISYS INC (AMED) Stock Analyst Earnings Estimates

NASDAQ:AMED - Nasdaq - US0234361089 - Common Stock - Currency: USD

92.5  +0.09 (+0.1%)

After market: 92.5 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
AMED revenue by date.AMED revenue by date.
2.214B
6.88%
2.223B
0.41%
2.236B
0.59%
2.395B
7.09%
2.519B
5.18%
2.671B
6.03%
EBITDA
YoY % growth
AMED ebitda by date.AMED ebitda by date.
303.5M
39.28%
217.7M
-28.27%
216.913M
-0.36%
255.61M
17.84%
273.78M
7.11%
296.32M
8.23%
EBIT
YoY % growth
AMED ebit by date.AMED ebit by date.
272.6M
44.16%
192.8M
-29.27%
193.066M
0.14%
226.15M
17.14%
238.58M
5.50%
268.44M
12.52%
Operating Margin
AMED operating margin by date.AMED operating margin by date.
12.31%8.67%8.63%9.44%9.47%10.05%
EPS
YoY % growth
AMED eps by date.AMED eps by date.
5.94
-2.94%
5.01
-15.66%
4.29
-14.37%
4.48
4.38%
5.02
12.05%
5.47
8.97%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
1.10
16.78%
1.13
9.92%
1.45
9.73%
1.17
17.10%
1.22
11.50%
1.32
16.22%
1.451.39
18.47%
1.33
8.33%
Revenue
Q2Q % growth
607.85M
6.49%
613.51M
7.37%
630.91M
6.72%
635.89M
8.21%
643.43M
5.85%
682.38M
11.23%
678.3M
7.51%
698.7M
9.88%
695.64M
8.11%
EBITDA
Q2Q % growth
61.649M
-11.14%
63.878M
9.34%
78.822M
2.89%
65.685M
-0.97%
66.751M
8.28%
72.42M
13.37%
78.54M
-0.36%
75.48M
14.91%
72.42M
8.49%
EBIT
Q2Q % growth
52.435M
15.17%
55.19M
5.55%
70.047M
9.25%
56.365M
19.93%
56.31M
7.39%
66.912M
21.24%
73.236M
4.55%
70.278M
24.68%
67.218M
19.37%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
1.00
2.04%
1.19-0.19-15.99%
Q2 2024
Q2Q % growth
1.32
-3.65%
1.210.119.21%
Q1 2024
Q2Q % growth
1.03
3.00%
1.04-0.01-1.00%
Q4 2023
Q2Q % growth
0.94
-18.97%
1.05-0.11-10.67%
Q3 2023
Q2Q % growth
0.98
-14.78%
1.10-0.12-10.95%
Q2 2023
Q2Q % growth
1.37
-6.80%
1.110.2623.03%
Q1 2023
Q2Q % growth
1.00
-18.70%
0.900.1010.84%
Q4 2022
Q2Q % growth
1.16
-1.69%
1.020.1413.24%
Q3 2022
Q2Q % growth
1.15
-24.84%
1.24-0.09-7.32%
Q2 2022
Q2Q % growth
1.47
-13.02%
1.250.2217.16%
Q1 2022
Q2Q % growth
1.23
-20.13%
1.150.087.27%
Q4 2021
Q2Q % growth
1.18
-20.81%
1.20-0.02-1.66%
Q3 2021
Q2Q % growth
1.53
-31.70%
1.390.149.73%
Q2 2021
Q2Q % growth
1.69
26.12%
1.70-0.01-0.46%
Q1 2021
Q2Q % growth
1.54
46.67%
1.460.085.81%
Q4 2020
Q2Q % growth
1.49
58.51%
1.50-0.01-0.59%
Q3 2020
Q2Q % growth
2.24
94.78%
1.290.9573.02%
Q2 2020
Q2Q % growth
1.34
10.74%
0.830.5161.52%
Q1 2020
Q2Q % growth
1.05
-5.41%
0.990.066.16%
Q4 2019
Q2Q % growth
0.94 0.940.00-0.45%
Q3 2019
Q2Q % growth
1.15 0.910.2425.97%
Q2 2019
Q2Q % growth
1.21 1.010.2020.23%
Q1 2019
Q2Q % growth
1.11 0.920.1920.71%
AMED Yearly EPS VS EstimatesAMED Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
587.671M
5.65%
599.81M-12.139M-2.02%
Q2 2024
Q2Q % growth
591.187M
6.91%
590.4M787K0.13%
Q1 2024
Q2Q % growth
571.414M
2.70%
576.69M-5.276M-0.91%
Q4 2023
Q2Q % growth
570.788M
1.55%
579.07M-8.282M-1.43%
Q3 2023
Q2Q % growth
556.237M
-0.32%
572.49M-16.253M-2.84%
Q2 2023
Q2Q % growth
552.968M
-0.88%
579.56M-26.592M-4.59%
Q1 2023
Q2Q % growth
556.389M
2.03%
570.16M-13.771M-2.42%
Q4 2022
Q2Q % growth
562.1M
0.50%
574.86M-12.76M-2.22%
Q3 2022
Q2Q % growth
558M
0.81%
590.82M-32.82M-5.55%
Q2 2022
Q2Q % growth
557.9M
-1.12%
594.79M-36.89M-6.20%
Q1 2022
Q2Q % growth
545.3M
1.53%
570.02M-24.72M-4.34%
Q4 2021
Q2Q % growth
559.3M
1.56%
566.3M-7M-1.24%
Q3 2021
Q2Q % growth
553.5M
1.73%
579.74M-26.24M-4.53%
Q2 2021
Q2Q % growth
564.2M
16.31%
577.51M-13.31M-2.30%
Q1 2021
Q2Q % growth
537.1M
9.23%
555.76M-18.66M-3.36%
Q4 2020
Q2Q % growth
550.7M
9.99%
564.44M-13.74M-2.43%
Q3 2020
Q2Q % growth
544.1M
10.01%
543.84M260K0.05%
Q2 2020
Q2Q % growth
485.1M
-1.60%
478.51M6.59M1.38%
Q1 2020
Q2Q % growth
491.7M
5.22%
514.95M-23.25M-4.52%
Q4 2019
Q2Q % growth
500.7M 521.78M-21.08M-4.04%
Q3 2019
Q2Q % growth
494.6M 504.04M-9.44M-1.87%
Q2 2019
Q2Q % growth
493M 499.17M-6.17M-1.24%
Q1 2019
Q2Q % growth
467.3M 469.82M-2.52M-0.54%
AMED Yearly Revenue VS EstimatesAMED Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B 2.5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -5.89% 0% -5.84%
Revenue0% 0.22% 0.04% 0.04%